After Pandemic Ravaged Nursing Homes, New State Laws Protect Residents
This year, 23 states passed more than 70 pandemic-related provisions affecting nursing homes, including measures setting minimum staffing levels, expanding visitation protections and limiting owners’ profit margins.
Biden’s No-Jab-No-Job Order Creates Quandary for Nursing Homes
Nursing home operators acknowledge that large numbers of staff members are not getting the shots but fear a federal vaccination mandate could drive away workers in a tight labor market.
KHN’s ‘What the Health?’: Booster Time
As the delta variant continues to spread around the U.S., the Biden administration is taking steps to authorize covid vaccine boosters, require nursing home workers to be vaccinated and protect school officials who want to require masks despite state laws banning those mandates. Meanwhile, the U.S. House is returning from its summer break early to start work on its giant budget bill, which includes a long list of health policy changes. Alice Miranda Ollstein of Politico, Margot Sanger-Katz of The New York Times and Kimberly Leonard of Business Insider join KHN’s Julie Rovner to discuss these issues and more.
Why Doesn’t Medicare Cover Services So Many Seniors Need?
When the program began half a century ago, backers believed the benefits would expand over time, but politics and concerns about money have stymied most efforts. Now congressional Democrats are looking to add vision, dental and hearing care.
Injuries Mount as Sales Reps for Device Makers Cozy Up to Surgeons, Even in Operating Rooms
Aggressive sales tactics have allegedly led surgeons to use defective or wrong-size implants, screws or other products on patients, including former Olympian Mary Lou Retton.
Clarity on Covid Count: Pandemic’s Toll on Seniors Extended Well Beyond Nursing Homes
The latest research shows that although deaths in nursing homes received enormous attention, far more older adults who perished from covid lived outside of institutions. People with dementia and other severe neurological conditions, chronic kidney disease and immune deficiencies were hit especially hard.
“Sabiduría y miedo” llevan al 90% de los adultos mayores de EE.UU. a vacunarse contra covid
La pandemia ha sido especialmente cruel para los adultos mayores. Casi el 80% de las muertes ocurrieron entre personas de 65 años y más. Millones estuvieron aislados en residencias y en sus casas por meses.
‘Wisdom and Fear’ Lead 90% of U.S. Seniors to Covid Vaccines
The success in getting shots to older adults is likely due to states prioritizing that effort when the vaccines became available and motivation among the elderly after the virus killed so many in their age group.
Restoring a Sense of Belonging: The Unsung Importance of Casual Relationships for Older Adults
Relationships with people you know only superficially can help develop a sense of belonging and provide motivation to engage in activities. Research has found that older adults who have a broad array of “weak” as well as “close” ties enjoy better physical and psychological well-being and live longer than people with less diverse social networks.
Amid Covid Booster Debate, West Virginia to Check Immunity of Vaccinated Nursing Home Residents
The state says it will look at the levels of disease-fighting antibodies among nursing home residents vaccinated against covid, which could help indicate whether they need a booster shot.
Pfizer Court Fight Could Legalize Medicare Copays and Unleash ‘Gold Rush’ in Sales
Pharmaceutical companies routinely cover the cost of patient copays for expensive drugs under private insurance. A federal judge could make the practice legal for millions on Medicare as well.
Facing Headwinds on New Alzheimer’s Drug, Biogen Launches Controversial Campaign
The makers of Aduhelm, a drug approved last month despite concerns raised by experts about its effectiveness, have launched a website and ads designed to urge people who are worried about their memory to ask doctors about testing. But some health advocates say it is misleading because some memory loss with aging is normal.
A Chilling Cure: Facing Killer Heat, ERs Use Body Bags to Save Lives
Doctors in Washington state used human body bags filled with ice and water to rapidly cool the sickest patients affected by record heat last month.
Though Millions Are at Risk for Diabetes, Medicare Struggles to Expand Prevention Program
Medicare has proposed revamping its payment rules to get more people into a diabetes prevention plan that helps them eat better, exercise more and maintain a healthier lifestyle. Out of an estimated 16 million Medicare beneficiaries whose excess weight and other risk factors make them eligible, only 3,600 have participated since 2018.
Adolescentes voluntarios se abren paso como futuros profesionales en hogares de adultos mayores
Desde que se puso en marcha en 2006, el programa de desarrollo para la carrera en geriatría ha ayudado a más de 700 estudiantes de secundaria de 10 escuelas de bajos recursos, en la ciudad de Nueva York, a adquirir experiencia práctica en cuidados geriátricos.
Teen Volunteers Get a Foot in the Door for Nursing Home Careers
A group of New York senior living facilities offer teens from 10 underserved schools the chance to volunteer and get free training for entry-level health jobs, career coaching and assistance on college prep.
Why We May Never Know Whether the $56,000-a-Year Alzheimer’s Drug Actually Works
It could take years for follow-up studies to prove Aduhelm slows the disease — or doesn’t. Meanwhile, its maker will profit.
Doctors Weigh Pros and Cons of Prescribing Hot-Button Alzheimer’s Drug
The potential benefits of Aduhelm are small, its effectiveness is not certain, and even the FDA Thursday shifted its guidance on who should get the drug. But physicians are dealing with an onslaught of interest from patients and their families, and figuring out which patients are best positioned to be helped by the drug will be difficult.
Paying Billions for Controversial Alzheimer’s Drug? How About Funding This Instead?
Aduhelm, approved by the Food and Drug Administration last month despite questions about its efficacy, could be prescribed to at least 1 million patients a year, for a price tag of about $56 billion. Experts suggest there might be better ways to spend that money.
KHN’s ‘What the Health?’: Un-Trumping the ACA
The Biden administration is moving to undo many of the changes the Trump administration made to the enrollment process for the Affordable Care Act to encourage more people to sign up for health insurance. Meanwhile, Congress is opening investigations into the controversial approval by the Food and Drug Administration of an expensive drug that might (or might not) slow the progression of Alzheimer’s disease. Joanne Kenen of Politico, Kimberly Leonard of Insider and Sarah Karlin-Smith of the Pink Sheet join KHN’s Julie Rovner to discuss these issues and more. Also, Rovner interviews Marshall Allen of ProPublica about his new book, “Never Pay the First Bill: And Other Ways to Fight the Health Care System and Win.”
